Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure

NCT00902915 is registered in ClinicalTrials.gov with Austrian Forum Against Cancer as lead sponsor.

NCT NCT00902915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00902915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure
Lead sponsor
Austrian Forum Against Cancer
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2009
Completion date
May 31, 2014
Enrollment
50 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma light chain induced renal insufficiency